LPCN Lipocine Inc.

NASDAQ
$1.53

Lipocine Inc. (LPCN) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $0.33 per share.

Lipocine Beat Consensus Estimates
Thursday, November 5, 2026 · 8:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Nov 5
Thursday · 8:00 AM ET
Earnings Whisper
-
vs ($0.33)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.16

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Lipocine Inc.

Lipocine Inc is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.